CLDF Title
Contact Us | Bookmark
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
Live CME Meetings Telewebs Webcasts Slide Library Abstract Library Conference Highlights
Featured Programs
HighwayRx   Banner2   Banner4   Banner3
 
             
  Liver News - REUTERS   Congress Calendar   Physician Resources  
 
 
Restricting fructose intake may reduce kids' liver fat accumulation
03-19-2015
Charity attacks Gilead over hepatitis C drug restrictions
03-18-2015
New market for liver disease spawns race for better testing
03-18-2015
Steroids for Graves' eye disease may boost risk of statin hepatotoxicity
03-18-2015
View Complete News Library
 
 
April 22-26
The International Liver Congress 2015, 50th annual meeting of the European Association for the Study of the Liver (EASL)
Vienna, Austria
May 2-6
AMERICAN TRANSPLANT CONGRESS
Philadelphia, Pennsylvania
May 6-9
48th ANNUAL MEETING- THE EUROPEAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION (ESPGHAN)
Amsterdam, Netherlands
May 16-19
DDW 2015
Washington, DC
View all Congresses
 
 
 
 
  Line  
  Featured Abstracts          
 
Sofosbuvir for treatment of chronic hepatitis C
 
Chronic hepatitis C - what do the new drugs offer and who should get them first?
 
Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of the Hepatitis C Virus NS5B Polymerase Inhibitor Sofosbuvir
 
Comparison of Risk-Based Hepatitis C Screening and the True Seroprevalence in an Urban Prison System
 
Post-Liver Transplant Hepatitis C Therapy
 
New Medical Treatment Strategies for Nonalcoholic Steatohepatitis
 
 
A retrospective study of administration of vaccination for hepatitis B among newborn infants prior to hospital discharge at a midwestern tertiary care center
 
A Comparison of Patients With Hepatitis B- or Hepatitis C-Based Advanced-Stage Hepatocellular Carcinoma
 
Risk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment: Extending perspective from old to newer drugs
 
Genotypes and viral variants in chronic hepatitis B: A review of epidemiology and clinical relevance
 
Salivary Microbiota Reflects Changes in Gut Microbiota in Cirrhosis with Hepatic Encephalopathy
 
Psychoactive Medications Increase the Risk of Falls and Fall-Related Injuries in Hospitalized Patients with Cirrhosis
 
 
Interferon gamma, interleukin-6, and -17a levels were correlated with minimal hepatic encephalopathy in HBV patients
 
Nutrition in the management of cirrhosis and its neurological complications
 
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
 
Management of hepatocellular carcinoma with portal vein thrombosis
 
The evolving epidemiology of hepatocellular carcinoma: a global perspective
 
Overexpression of C-reactive Protein as a Poor Prognostic Marker of Resectable Hepatocellular Carcinomas
 
 
          View All Abstracts  
  Line  
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Live CME Meetings
Telewebs
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Regional Map
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2015 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.